You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美麗田園醫療健康(02373.HK):超額配股權獲悉數行使、涉及608萬股

格隆匯2月5日丨美麗田園醫療健康(02373.HK)宣佈,招股章程所述的超額配股權已獲整體協調人(為其本身以及代表資本市場中介人及國際包銷商)於2023年2月3日(交易時段後)悉數行使,當中涉及合共608萬股股份(“超額配發股份”)(佔任何超額配股權獲行使前全球發售項下初步可供認購發售股份總數約15%),以便向LIY Management Holdings Limited歸還根據借股協議借入用作補足國際發售下超額分配的608萬股股份。

公司將按全球發售項下每股發售股份的發售價每股股份19.32港元(不包括1%經紀佣金、0.0027%證監會交易徵費、0.00565%聯交所交易費及0.00015%會財局交易徵費)發行及配發超額配發股份。

公司進一步宣佈,根據香港法例第571W章證券及期貨(穩定價格)規則第9(2)條,有關全球發售的穩定價格期已於2023年2月5日(即遞交香港公開發售申請截止日期後第30日)結束。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account